
Kills 99.99% of airborne COVID-19 so you don't inhale it

Kills all other floating pathogens: flu, MRSA, C. difficile, mold, etc.

Employees feel safer at work knowing the air is disinfected

Customers feel safe returning to your business

"The Novaerus Plasma technology rapidly inactivates the DNA in pathogens."
Dr. Ram Prasad Gandhiraman
Research Scientist, NASA

"The bacteria underwent physical distortion of varying degrees, resulting in the deformation of the bacterial structure."
Ames Research Center
NASA
Clean Air Inside
Keep everyone in your business safe, including you.
Our Clean Air Inside campaign shows the public that Novaerus disinfect the air in your business. Our signage is bright, bold, and reassuring. This new seal of approval is the assurance your customers need to choose you over a competitor.
Your Staff
Having a proven system in place alleviates fears employees have about working together with others during the pandemic. Also, consider that a single person testing positive at your business will force your entire staff to quarantine until they're tested.
Your Customers
Customers are returning to business have strong cleaning protocols and systems that disinfect indoor air.
You
There is no way to know what viruses and bacteria people are bringing into your business. Make it a safe environment for everyone, including those you go home to each night.

It's not a filter
YOU NEED TO KNOW THE DIFFERENCE

Plasma Kills 99.99% of Pathogens
Electrified plasma kills 99.99% of pathogens on contact at the DNA/RNA level. With plasma, the pathogen is destroyed and cannot heal, mutate, or reproduce.

Filters Only Trap Pathogens
Filters trap pathogens in a layer of fabric. Viruses are smaller than filters can capture and pass through them without being trapped. Bacteria can colonize on the fabric and grow. If there is any breach in the filter material the bacteria and mold is spread back into the room.
Three Models to Protect Your Business

NV200
Designed for exam rooms, bedrooms, or any room up to 200 square feet. This model is also used in hospital rooms with COVID-19 positive patients to protect healthcare staff.
- For rooms up to 200 square feet
- Specifications
- Independent study

NV900
Used in common areas and larger rooms of up to 1,200 square feet. This model is often found in nursing stations, patient lobbies, and work areas.
- For rooms up to 1,200 square feet
- Wall or stand mounted
- 2 Speed Fan
- 1-year warranty (extendable to 3 years)
- No filters required

NV1050
The NV1050 covers up to 4,000 square feet and is used for the immediate remediation of viruses, bacteria, and fungus in common areas. This device is typically used in larger areas (ex. emergency room lobby) or in COVID-19 wards.
- For rooms up to 4,000 square feet
- Specifications
- Independent study
Contact us today at (800) 977-3002

Or, download our information kit here:
Independent Lab Testing

Viruses
Name | Reduc. | Model |
---|---|---|
SARS-CoV-2 |
99.99% | NV1050 |
Measles |
99.87% | NV1050 |
Influenza A |
99.9% | NV1050 |
Phi X 174 |
98.8% | NV1050 |
SARS-CoV-2 |
99.99% | NV900 |
Norovirus |
99.99% | NV900 |
Influenza A |
99.99% | NV900 |
The links below are being updated. If the report you're looking for isn't available, call us: 800-977-3002.
Case Studies
Broward Children's Comprehensive Care Center
This 20-month study compares the total number of respiratory nosocomial infections before and after implementation of the Novaerus technology.
Caledonia-Mumford CSD Case Study
Novaerus technology improves air quality for students and staff with high attendance during record flu season.
Canternury Tower Case Study
This 35-month study compares the total number of respiratory nosocomial infections and infection rates before and after implementation of the Novaerus technology.
Edgehill Senior Living Case Study
This 24-month study compares the total number of respiratory nosocomial infections before and after implementation of the Novaerus technology.
Haus an der Traisen Case Study
Since 2014, the Haus an der Traisen nursing home in St. Polten, Austria has supplemented their existing hygiene protocols with Novaerus air purification units to help control infection and recuse odor.
Hialeah Nursing and Rehab Center (HNRC)
This 24-month study compares the total number of repeat infections, nosocomial C. difficile infections, and nosocomial respiratory infections before and after implementation of the Novaerus technology.
Linde Healthcare Case Study
Linde Healthcare, a Vienna based company, had no existing healthy air solution in place for its 16-person open floorplan office space. Curious about Novaerus' innovative technology, they reached out to learn more.
Mamos Delne Case Study
After learning about the safety and efficacy of Novaerus' low-energy plasma technology, Kindergarten Mamos Delne tried the technology in each of their three classrooms.
Manchester Manor Case Study
This 24-month study compares the total number of nosocomial respiratory infections and nosocomial C. difficile infections before and after implementation of the Novaerus technology.
Masfiv Medical Center, Spain
As COVID-19 rapidly spread across the globe, healthcare facilities around the world had to adapt and prepare for a pandemic. For Masfiv, the newly built medical center specializing in reproductive medicine and gynecological health, this meant maintaining minimal essential reproductive care while containing the spread of Coronavirus. In line with public health guidelines, Masfiv established a range of COVID-19 protocols. One of these protocols; 24/7 air dis-infection technology by Novaerus.
Meadow View Case Study
This 24-month study compares the total number of nosocomial respiratory infections before and after implementation of Novaerus technology.
Naamans Creek Case Study
This 28-month study compares the total number of nosocomial respiratory infections and nosocomial C. difficile infections before and after the implementation of Novaerus technology.
Page Case Study
This 29-month study compares the average monthly rate of nosocomial respiratory infections before and after implementation of the Novaerus technology.
Patki Hospital, India
Patki Hospital, an IVF center, specialized in obstetrics, infertility and gynecology were looking for a solution to reduce airborne VOC and infection load in their lab. After investigating various options the hospital decided to deploy a Novaerus Defend 1050. The result; improved outcomes and air quality.
Sante International Case Study
Sante International has provided solutions to the Romanian healthier industry since 1992 and has partnered with Novaerus since 2014. Over a 3-month period, they proved Novaerus technology is more efficient and safer with no maintenance and at a low cost.
Tortoise Rock Casino Case Study
Plasma Air HVAC technology created a healthier breathing environment for patrons and employees in a 30,000 square foot casino.
University Biology Lab Case Study
Plasma Air technology improved air quality by reducing odors, particles, and toxins in a 1950's university biology building in Louisiana.
University of Szeged Case Study
As part of a trial to measure background pollution and pathogenic organisms, Novaerys units were placed in four locations in the University of Szeged's Department of Geriatrics and Chronic Disease clinics. The medical clinic was interested in improving overall air quality in the geriatric and chronic disease wards.
Clinical Trials
Evaluation of Novaerus Technology in a Dialysis Center
Novaerus reduces VOCs by 93%, airborne bacteria by 87%, and molds by 67%
Facility:
Fresenius Dialysis Centers
Evaluation of Novaerus Technology in a Dialysis Center
Novaerus reduces VOCs by 93%, airborne bacteria by 87%, and molds by 67%
Facility:
Fresenius Dialysis Centers
Evaluation of Novaerus Technology in a Hospital
Novaerus reduces environmental surface MRSA by 97% and reduces environmental surface TVC and environmental air MRSA.
Facility:
Royal Free Hospital; Hampstead, London
Evaluation of Novaerus Technology in an Opthalmology Operating Room
Novaerus reduces bacterial colony count in both the rooms that were being used and those that were empty.
Evaluation of Novaerus Technology in a Nephrology Clinic
Novaerus was shown to reduce bacterial loads on high surfaces and window sills as well as reduce overall infection rates by 23% compared to an increase of infection rated by 35% in the control section.
Evaluation of Novaerus Technology in a Pediatric Department
Novaerus devices effectively reduce the number of airborne pathogens by 61% in the admission room of the pediatric department and by 19% in a pulmonology clinic.
Evaluation of Novaerus Technology in a Pulmonology Department
Novaerus reduces CFU rates by 82% and fungi count by 93% after two months of operation.
Evaluation of Novaerus in an Infectious Disease Unit
Novaerus devices significantly reduce the number of microorganisms as well as eliminate unwanted odors.